Loading...

Illumina, Inc.

ILMN•NASDAQ
Healthcare
Medical - Diagnostics & Research
$127.88
$2.44(1.95%)
U.S. Market opens in 23h 4m

Illumina, Inc. (ILMN) Stock Overview

Explore Illumina, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap19.6B
P/E Ratio23.00
EPS (TTM)$5.45
ROE0.35%
Fundamental Analysis

AI Price Forecasts

1 Month$116.35
3 Months$80.27
1 Year Target$89.80

ILMN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Illumina, Inc. (ILMN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 49.78, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $89.80.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 23.00 and a market capitalization of 19.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.95%
5-Day Change
-4.19%
1-Month Change
1.51%
3-Month Change
-14.91%
6-Month Change
27.74%
Year-to-Date (YTD) Change
-2.50%
1-Year Change
64.77%
3-Year Change
-42.56%
5-Year Change
-68.73%
All-Time (Max) Change
571.99%

Contact Information

https://www.illumina.com
858 202 4500
5200 Illumina Way, San Diego, CA, 92122

Company Facts

8,970 Employees
IPO DateJul 28, 2000
CountryUS
Actively Trading

Frequently Asked Questions